Brief: Cipla Receives USFDA Approval For First AB-Rated Generic Of Ventolin HFA
April 23 (Reuters) - Cipla Ltd CIPL.NS: RECEIVES USFDA APPROVAL FOR FIRST AB-RATED GENERIC OF VENTOLIN HFA TO LAUNCH GENERIC VENTOLIN HFA IN US IN H1 FY2026-27 Source text: ID:nBSE6Gs3WS Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate